These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre. Wallaschofski H; Kuwert T; Lohmann T Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319 [TBL] [Abstract][Full Text] [Related]
3. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose]. Bakker SC; Zanin DE; Zweers EJ Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370 [TBL] [Abstract][Full Text] [Related]
4. Thyroid hemiagenesis with Graves' disease, Graves' ophthalmopathy and multinodular goiter. Cakir M; Gonen S; Dikbas O; Ozturk B Intern Med; 2009; 48(12):1047-9. PubMed ID: 19525596 [TBL] [Abstract][Full Text] [Related]
5. Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease. Kim WB; Han SM; Kim TY; Nam-Goong IS; Gong G; Lee HK; Hong SJ; Shong YK Clin Endocrinol (Oxf); 2004 Jun; 60(6):719-25. PubMed ID: 15163336 [TBL] [Abstract][Full Text] [Related]
6. Aetiology of hyperthyroidism in Canada and Wales. Williams I; Ankrett VO; Lazarus JH; Volpe R J Epidemiol Community Health; 1983 Sep; 37(3):245-8. PubMed ID: 6688631 [TBL] [Abstract][Full Text] [Related]
7. Thyroid cancer in patients with hyperthyroidism. Gabriele R; Letizia C; Borghese M; De Toma G; Celi M; Izzo L; Cavallaro A Horm Res; 2003; 60(2):79-83. PubMed ID: 12876418 [TBL] [Abstract][Full Text] [Related]
8. Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management. Díez JJ Gerontology; 2003; 49(5):316-23. PubMed ID: 12920352 [TBL] [Abstract][Full Text] [Related]
9. Increased aggressiveness of thyroid cancer in patients with Graves' disease. Belfiore A; Garofalo MR; Giuffrida D; Runello F; Filetti S; Fiumara A; Ippolito O; Vigneri R J Clin Endocrinol Metab; 1990 Apr; 70(4):830-5. PubMed ID: 2180978 [TBL] [Abstract][Full Text] [Related]
11. [Hyperthyroidism and carcinoma of the thyroid gland]. Ardito G; Mantovani M; Vincenzoni C; Guidi ML; Corsello S; Rabitti C; Fadda G; Di Giovanni V Ann Ital Chir; 1997; 68(1):23-7; discussion 27-8. PubMed ID: 9235859 [TBL] [Abstract][Full Text] [Related]
12. Do thyroid-stimulating immunoglobulins cause non-toxic and toxic multinodular goitre? Brown RS; Jackson IM; Pohl SL; Reichlin S Lancet; 1978 Apr; 1(8070):904-6. PubMed ID: 76846 [TBL] [Abstract][Full Text] [Related]
13. [Thyroid antibodies and their diagnostic value]. Schneidinger P; Joller-Jemelka H; Grob PJ Schweiz Med Wochenschr; 1985 Nov; 115(44):1536-44. PubMed ID: 3841229 [TBL] [Abstract][Full Text] [Related]
14. Hyperthyroidism due to Graves' disease and due to autonomous goiter. Schicha H; Emrich D; Schreivogel I J Endocrinol Invest; 1985 Oct; 8(5):399-407. PubMed ID: 3841136 [TBL] [Abstract][Full Text] [Related]
15. Graves' disease, multinodular goiter and subclinical hyperthyroidism. Bel Lassen P; Kyrilli A; Lytrivi M; Corvilain B Ann Endocrinol (Paris); 2019 Sep; 80(4):240-249. PubMed ID: 31427038 [TBL] [Abstract][Full Text] [Related]
16. Sequential presentation of a case of hyperthyroidism with autonomously functioning nodules and Graves' disease in the presence of IgG thyroid stimulators. Smyth PP; Neylan D; McMullan NM; Smith DF; McKenna TJ Acta Endocrinol (Copenh); 1988 Aug; 118(4):474-8. PubMed ID: 2899938 [TBL] [Abstract][Full Text] [Related]
17. Thyroid cancer in patients with hyperthyroidism. Pazaitou-Panayiotou K; Michalakis K; Paschke R Horm Metab Res; 2012 Apr; 44(4):255-62. PubMed ID: 22334393 [TBL] [Abstract][Full Text] [Related]
18. Incidental papillary thyroid carcinoma in a patient presenting with Graves' hyperthyroidism and concomitant obstructive sequestered intrathoracic multinodular goiter. Ciarallo A; Makis W; Novales-Diaz JA Clin Nucl Med; 2011 Feb; 36(2):145-7. PubMed ID: 21220984 [TBL] [Abstract][Full Text] [Related]
19. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays. Pedersen IB; Knudsen N; Perrild H; Ovesen L; Laurberg P Clin Endocrinol (Oxf); 2001 Sep; 55(3):381-90. PubMed ID: 11589682 [TBL] [Abstract][Full Text] [Related]
20. [Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study]. Reinwein D; Benker G; König MP; Pinchera A; Schatz H; Schleusener H Schweiz Med Wochenschr; 1987 Aug; 117(34):1245-55. PubMed ID: 3672070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]